Skip to content

Drug interactions

Degarelix + Tiotropium-olodaterol

Severity: Moderate

Degarelix and Tiotropium-olodaterol: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Androgen deprivation therapy with degarelix can prolong the QT interval, and olodaterol may add to arrhythmia risk through sympathetic stimulation and hypokalemia. The overall risk is modest but relevant in patients with heart disease.

What this interaction means in plain words

Degarelix and Tiotropium-olodaterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Degarelix belongs to Endocrine; Tiotropium-olodaterol belongs to Respiratory.

Evidence level: Low

Why it happens

Additive effects on cardiac repolarization together with beta2-mediated sympathetic stimulation.

What to do

Consider baseline and periodic ECG in patients with cardiac risk factors and correct electrolyte abnormalities.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Degarelix and Tiotropium-olodaterol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Degarelix with Tiotropium-olodaterol?

MediHelp rates the interaction as moderate. Degarelix and Tiotropium-olodaterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Androgen deprivation therapy with degarelix can prolong the QT interval, and olodaterol may add to arrhythmia risk through sympathetic stimulation and hypokalemia. The overall risk is modest but relevant in patients with heart disease.

How serious is the interaction between Degarelix and Tiotropium-olodaterol?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider baseline and periodic ECG in patients with cardiac risk factors and correct electrolyte abnormalities.

What other medicines interact with Tiotropium-olodaterol?

MediHelp also lists interactions of Tiotropium-olodaterol with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Tiotropium-olodaterol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in